XML 54 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Employee Stock and Benefit Plans (Tables)
 12 Months Ended
Oct. 02, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense Recognized in the Consolidated Financial Statements Stock-based compensation expense recognized in the consolidated financial statements (in millions):
Fiscal Year EndedOct 2, 2022Oct 3, 2021Sep 27, 2020
RSUs$271.8 $316.9 $241.0 
Options(0.2)2.2 7.5 
Total stock-based compensation expense recognized in the consolidated statements of earnings$271.6 $319.1 $248.5 
Total related tax benefit$45.9 $51.6 $47.8 
Total capitalized stock-based compensation included in net property, plant and equipment on the consolidated balance sheets$3.9 $3.7 $3.6 
Stock Options Granted During the Period, Valuation Assumptions The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal 2022, 2021 and 2020:
Stock Options
Granted During the Period
Fiscal Year Ended202220212020
Expected term (in years)0.08.17.8
Expected stock price volatility— %26.3 %27.3 %
Risk-free interest rate— %1.4 %1.2 %
Expected dividend yield— %1.6 %2.9 %
Weighted average grant price$— $110.46 $56.33 
Estimated fair value per option granted$— $27.59 $11.30 
Stock Option Transactions Stock option transactions for the fiscal year ended October 2, 2022 (in millions, except per share and contractual life amounts):
Shares
Subject to
Options		Weighted
Average
Exercise
Price
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Outstanding, October 3, 20215.2 $54.58 4.5$303 
Granted— — 
Exercised(1.1)49.82 
Expired/forfeited0.0 48.45 
Outstanding, October 2, 20224.1 55.86 3.6117 
Exercisable, October 2, 20224.1 55.86 3.6117 
Vested and expected to vest, October 2, 20224.1 55.86 3.6117 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity RSU transactions for the fiscal year ended October 2, 2022 (in millions, except per share and contractual life amounts):
Number
of
Shares		Weighted
Average
Grant Date
Fair Value
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Nonvested, October 3, 20217.7 $86.23 0.9$869 
Granted4.2 107.71 
Vested(3.7)80.02 
Forfeited/canceled(1.2)100.04 
Nonvested, October 2, 20227.0 98.88 1.0587